Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients with Type 2 Diabetes and CKD: A Post Hoc Analysis of the CREDENCE Trial

Category Primary study
JournalJournal of the American Society of Nephrology : JASN
Year 2023
This article has no abstract
Epistemonikos ID: 4528cc5f069a6fa3b79acf6f17ca68916cbf5bbb
First added on: Dec 07, 2023